Keyphrases
Antigen-specific
9%
Antigen-specific T Cells
28%
Antigenic Peptide
9%
Autoreactive T Cells
21%
Cancer Cells
9%
Cancer Immunotherapy
9%
CD4+ T Cells
19%
CD8+ Tumor-infiltrating Lymphocytes
8%
Cell Response
7%
Colorectal Cancer
19%
Complementary DNA (cDNA)
10%
Cross-species
19%
Effector Memory T Cells
19%
Function Analysis
19%
Human Breast Cancer
19%
IgM Antibody
9%
Induced Apoptosis
9%
Infiltrating Lymphocytes
19%
Interferon-γ
10%
Leishmania
15%
Leishmaniasis
7%
Ligand-receptor Binding
9%
Mouse T Cells
21%
Multiple Markers
9%
NKG2D
19%
Oligoclonal Bands
10%
Omicron Spike
9%
Ovalbumin
15%
PD-1 Expression
23%
Phosphoenolpyruvate Carboxylase
19%
Programmed Death-ligand 1 (PD-L1)
21%
Rapid Cloning
9%
Receptor 1
9%
Receptor Function
19%
Single-cell Analysis
19%
Soluble Leishmania Antigen
19%
Spike Receptor Binding Domain
9%
T Cell Activation
9%
T Cell Receptor
87%
T Cells
24%
T-cell Receptor Repertoire
20%
TCR Gene Therapy
10%
Tumor
27%
Tumor Antigen
14%
Tumor Microenvironment
21%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
9%
Tumor Reactivity
12%
Tumor-infiltrating Lymphocytes
46%
Tumor-specific T Cells
8%
Tumoricidal Activity
19%
Immunology and Microbiology
Adoptive Immunity
7%
Antigen Specificity
37%
Cancer Cell
9%
CD8
6%
Cytotoxic T-Cell
19%
Hapten
9%
Immunoglobulin M Antibody
9%
Immunology
7%
Immunotherapy
8%
Isotype
9%
Leishmania
19%
Leishmaniasis
7%
Lymphocyte
19%
Monoclonal Antibody
9%
NKG2D
19%
Omicron Coronavirus Variant
5%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Single Cell Analysis
19%
Spike
9%
T Cell
62%
T Cell Receptor
100%
T-Helper Cell
19%
TNF related apoptosis inducing ligand
9%
Tumor Antigen
13%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
9%
Tumor-Infiltrating Lymphocytes
45%
Biochemistry, Genetics and Molecular Biology
Antigen Specificity
11%
Cancer Cell
9%
CD8
5%
Immunoglobulin M
9%
Single-Cell Analysis
19%
T Cell
24%
T Cell Receptor
57%
TRAIL
6%
Tumor Necrosis Factor
9%
Tumor-Infiltrating Lymphocytes
38%
